183 related articles for article (PubMed ID: 2234508)
21. Inhibitory influences of FMRFamide on morphine- and deprivation-induced feeding.
Kavaliers M; Hirst M; Mathers A
Neuroendocrinology; 1985 Jun; 40(6):533-5. PubMed ID: 4010892
[TBL] [Abstract][Full Text] [Related]
22. Supraspinal antinociception produced by [D-Met2]-FMRFamide in mice.
Raffa RB; Connelly CD
Neuropeptides; 1992 Jul; 22(3):195-203. PubMed ID: 1331846
[TBL] [Abstract][Full Text] [Related]
23. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis.
Dupouy V; Zajac JM
Regul Pept; 1995 Nov; 59(3):349-56. PubMed ID: 8577940
[TBL] [Abstract][Full Text] [Related]
24. Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain.
Rothman RB; Brady LS; Xu H; Long JB
Peptides; 1993; 14(6):1271-7. PubMed ID: 8134310
[TBL] [Abstract][Full Text] [Related]
25. Analogues of F8Famide resistant to degradation, with high affinity and in vivo effects.
Gicquel S; Mazarguil H; Allard M; Simonnet G; Zajac JM
Eur J Pharmacol; 1992 Nov; 222(1):61-7. PubMed ID: 1468500
[TBL] [Abstract][Full Text] [Related]
26. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
27. Restraint-induced analgesia in the CD-1 mouse: interactions with morphine and time of day.
Miller DB
Brain Res; 1988 Nov; 473(2):327-35. PubMed ID: 3233495
[TBL] [Abstract][Full Text] [Related]
28. Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat.
Oberling P; Stinus L; Le Moal M; Simonnet G
Peptides; 1993; 14(5):919-24. PubMed ID: 8284268
[TBL] [Abstract][Full Text] [Related]
29. Neuropeptide FF receptors: structure-activity relationship and effect of morphine.
Payza K; Akar CA; Yang HY
J Pharmacol Exp Ther; 1993 Oct; 267(1):88-94. PubMed ID: 8229791
[TBL] [Abstract][Full Text] [Related]
30. FMRF-amide and L-Arg-L-Phe increase blood pressure and heart rate in the anaesthetised rat by central stimulation of the sympathetic nervous system.
Thiemermann C; al-Damluji S; Hecker M; Vane JR
Biochem Biophys Res Commun; 1991 Feb; 175(1):318-24. PubMed ID: 1998514
[TBL] [Abstract][Full Text] [Related]
31. Supraspinal FMRFamide antagonizes morphine-induced horizontal, but not vertical, locomotor activity.
Raffa RB
Peptides; 1989; 10(2):403-6. PubMed ID: 2755878
[TBL] [Abstract][Full Text] [Related]
32. Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice.
Gelot A; Francés B; Gicquel S; Zajac JM
Eur J Pharmacol; 1998 Oct; 358(3):203-6. PubMed ID: 9822885
[TBL] [Abstract][Full Text] [Related]
33. Are Phe-Met-Arg-Phe-NH2 immunoreactive peptides endacoids modulating opiate antinociception?
Yang HY; Tang J; Iadarola M; Panula P; Costa E
Prog Clin Biol Res; 1985; 192():313-22. PubMed ID: 3909160
[TBL] [Abstract][Full Text] [Related]
34. Identification of neuropeptide FF-related peptides in rodent spinal cord.
Bonnard E; Burlet-Schiltz O; Francés B; Mazarguil H; Monsarrat B; Zajac JM; Roussin A
Peptides; 2001 Jul; 22(7):1085-92. PubMed ID: 11445238
[TBL] [Abstract][Full Text] [Related]
35. Elevation of arterial pressure in rats by two new vertebrate peptides FLFQPQRF-NH2 and AGEGLSSPFWSLAAPQRF-NH2 which are immunoreactive to FMRF-NH2 antiserum.
Roth BL; Disimone J; Majane EA; Yang HY
Neuropeptides; 1987 Jul; 10(1):37-42. PubMed ID: 3670567
[TBL] [Abstract][Full Text] [Related]
36. Biochemical, cellular and pharmacological activities of a human neuropeptide FF-related peptide.
Gelot A; Mazarguil H; Dupuy P; Francés B; Gouardères C; Roumy M; Zajac JM
Eur J Pharmacol; 1998 Aug; 354(2-3):167-72. PubMed ID: 9754917
[TBL] [Abstract][Full Text] [Related]
37. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
[TBL] [Abstract][Full Text] [Related]
38. Central effects of neuropeptide FF on intestinal motility in naive and morphine-dependent rats.
Gelot A; Fioramonti J; Zajac JM; Bueno L
Neuropeptides; 1995 Nov; 29(5):245-50. PubMed ID: 8587659
[TBL] [Abstract][Full Text] [Related]
39. A molecularly defined cardiorespiratory interneuron expressing SDPFLRFamide/GDPFLRFamide in the snail Lymnaea: monosynaptic connections and pharmacology.
Skingsley DR; Bright K; Santama N; van Minnen J; Brierley MJ; Burke JF; Benjamin PR
J Neurophysiol; 1993 Mar; 69(3):915-27. PubMed ID: 8096540
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of spontaneous and opiate-modified nociception by an endogenous neuropeptide with Phe-Met-Arg-Phe-NH2-like immunoreactivity.
Tang J; Yang HY; Costa E
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):5002-5. PubMed ID: 6589644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
